Sanjivani Parenteral Ltd. has received approval from BSE Limited to trade 197,394 equity shares at a premium of Rs. 125.10, effective January 13, 2025.
AI Assistant
Sanjivani Paranteral Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.